Advertisement
Screener

BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options, 2005

BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2005. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2005-12-06: Reporting owner Dobroff Lawrence; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2005-11-04: Reporting owner Dobroff Lawrence; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2005-10-06: Reporting owner Dobroff Lawrence; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2005-09-06: Reporting owner Dobroff Lawrence; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2005-12-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,149
18,012 owned after
$1.60
exercise price
2007-02-14
2005-11-04Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+2,315
16,863 owned after
$0.80
exercise price
2007-02-14
2005-10-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,476
14,548 owned after
$1.25
exercise price
2007-02-14
2005-09-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,082
13,072 owned after
$1.70
exercise price
2007-02-14
2005-08-05Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+921
11,990 owned after
$2.00
exercise price
2007-02-14
2005-07-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,701
11,069 owned after
$1.08
exercise price
2007-02-14
2005-06-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,754
9,368 owned after
$1.05
exercise price
2007-02-14
2005-05-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,543
7,614 owned after
$1.20
exercise price
2007-02-14
2005-04-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,543
6,071 owned after
$1.20
exercise price
2007-02-14
2005-03-04Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,149
4,528 owned after
$1.60
exercise price
2007-02-14
2005-02-04Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,149
3,379 owned after
$1.60
exercise price
2007-02-14
2005-01-06Dobroff Lawrence
Officer (Chief Financial Officer)
5Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,272
2,230 owned after
$1.45
exercise price
2007-02-14